Ex vivo administration of mesenchymal stromal cells in kidney grafts against ischemia reperfusion injury - effective delivery without kidney function improvement posttransplant
<p><strong>BACKGROUND:</strong> Mesenchymal stromal cell (MSC) therapy may improve renal function after ischemia-reperfusion injury in transplantation. Ex vivo renal intraarterial administration is a targeted delivery method, avoiding the lung vasculature, a known barrier for cellu...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Lippincott, Williams and Wilkins
2020
|